Close Menu

T2 Biosystems

The investment firm said the potential for T2's upcoming bacteria sepsis panel outweighs concerns over a lackluster launch for its Candida panel.

The company is also seeking regulatory approval for certain of its shareholders to sell up to $43 million in common stock from time to time.

The company also posted increased operating expenses related to R&D efforts and the added cost of doing business as a public company.

The loan amendment extends the deadline for drawing a $10 million tranche under the original loan agreement from June 30, 2015 to Dec. 31, 2015.

The investment bank said that T2 Biosystems is ahead of expectations in signing customers and placing its instruments.

The firm signed deals with a US hospital and a European reference lab for the T2Dx platform and T2 Candida sepsis test.

The investment bank maintained its stock ratings for Hologic, Cepheid, and T2 Biosystems.

The investment bank said the quick approval by the FDA for T2 Bio's platform and Candida test could signal high interest for the product in the medical community. 


The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.